Ibogaine and 5-MeO-DMT: The Difference, Explained

If you’ve been researching ibogaine treatment, you’ve likely encountered a second name: 5-MeO-DMT. Many of the leading ibogaine clinics in Mexico now offer both medicines as a combined protocol — and understanding why requires understanding what 5-MeO-DMT actually is and how it differs from ibogaine.

Is ibogaine the same as DMT?

No. Ibogaine and DMT are different compounds from different plants, with different mechanisms and very different durations. Ibogaine comes from the iboga shrub and works over 24–36 hours. DMT and 5-MeO-DMT are short-acting tryptamines that last minutes.

The confusion is understandable, because clinics often mention both in the same sentence. But they are not interchangeable, and one is not a shorter version of the other:

• Ibogaine is a monoterpenoid indole alkaloid from the root bark of Tabernanthe iboga, a shrub native to West and Central Africa. It acts on several systems at once — opioid, NMDA-glutamate, serotonin and nicotinic receptors — which is why it is studied for interrupting withdrawal rather than for producing a brief psychedelic state.
• 5-MeO-DMT is a simple tryptamine found in several plant species and in the venom of the Sonoran Desert toad. It acts primarily on the serotonin 5-HT_1A receptor.
• N,N-DMT — usually just called “DMT”, and the psychedelic compound in ayahuasca — is a third, separate molecule. It is not the one ibogaine clinics pair with ibogaine.

Both ibogaine and the tryptamines contain an indole ring, which is where the family resemblance ends. Ibogaine is not a tryptamine, and the two are not substitutes for one another.

Iboga, ibogaine, DMT and 5-MeO-DMT: what is the difference?

Iboga is the plant. Ibogaine is the single alkaloid extracted from it. DMT and 5-MeO-DMT are unrelated short-acting tryptamines — and 5-MeO-DMT, not DMT, is the one used alongside ibogaine in clinical protocols.

One practical point that tends to get lost: in a combined programme the two medicines are sequenced, never given together. 5-MeO-DMT is administered a day or more after the ibogaine session. Because ibogaine is by far the longer and more medically involved of the two, it is ibogaine that sets the screening and monitoring a credible programme puts in place. If a provider describes giving both at once, treat that as a reason to ask a great many more questions.

If it is the plant-versus-alkaloid distinction you are chasing rather than the DMT one, we cover that separately in ibogaine vs iboga. For the toad itself, see what is bufo.

What Is 5-MeO-DMT?

5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) is a naturally occurring psychedelic compound found in several plant species and in the venom of the Sonoran Desert toad (Incilius alvarius). It is one of the most potent psychedelic compounds known — but its effects are fundamentally different from classical psychedelics like psilocybin or LSD.

Where ibogaine produces a long, complex, narrative-rich experience lasting 24–36 hours, 5-MeO-DMT produces an intense but brief experience lasting 15–45 minutes. It is sometimes called “the God Molecule” because the experience it produces is often described as a complete dissolution of the sense of self — what researchers call “ego dissolution” — accompanied by a sense of unity or non-duality that many patients describe as the most profound experience of their lives.

How 5-MeO-DMT Works

5-MeO-DMT acts primarily on the serotonin 5-HT1A receptor — a different primary mechanism than classical psychedelics, which act primarily on 5-HT2A receptors. This distinction in mechanism appears to explain the qualitative difference in the experience: where psilocybin and LSD produce complex visual and cognitive effects, 5-MeO-DMT produces an experience that most patients describe as more primordial and less content-rich — a dissolution of boundaries rather than a journey through specific memories or imagery.

The Research on 5-MeO-DMT

We could not verify the 2023 study previously cited here, so we have removed it rather than leave it standing. What is verifiable is survey data: in Davis et al., J Psychopharmacol, 2018, among respondents who reported a psychiatric diagnosis, 79% said PTSD symptoms improved after 5-MeO-DMT use, 77% depression and 69% anxiety; a companion survey of 362 people found 80% reporting improved depression (Davis et al., Am J Drug Alcohol Abuse, 2019). Both are anonymous self-report surveys rather than trials — no control group, no independent measurement, and only people who chose to respond. A separate study found that 5-MeO-DMT increased psychological flexibility and mindfulness — markers that predict long-term resilience and wellbeing.

Why Clinics Combine Ibogaine and 5-MeO-DMT

The combination of ibogaine and 5-MeO-DMT has become a standard protocol at many leading clinics — particularly for patients dealing with PTSD, trauma, and treatment-resistant mental health conditions. The logic of the combination is complementary:

Ibogaine is described by many patients as a thorough, biographical process — a long journey through memory, pattern recognition, and psychological material that requires engagement and effort. It interrupts addiction and trauma at a physiological level while providing extensive psychological content to work with.

If you or someone close to you needs help right now, SAMHSA’s national helpline is free, confidential and staffed 24/7 on 1-800-662-HELP.

5-MeO-DMT is often described as the release after the work — a brief, intense experience of unity and openness that many patients find deeply healing in a way that is qualitatively different from the ibogaine experience. Many clinics administer 5-MeO-DMT one to two days after the ibogaine session, when the patient has completed the deep psychological work and is ready for a more transcendent integration experience.

What to Expect From 5-MeO-DMT

The experience begins within seconds of administration and reaches its full intensity within 1–5 minutes. At peak intensity, most patients report a complete loss of the sense of individual self — boundaries between self and environment dissolve. Many describe an experience of pure consciousness, infinite space, or profound peace. Some patients report challenging experiences of fear or disorientation during the onset.

The acute experience typically lasts 15–45 minutes, after which patients return to normal awareness gradually. Many describe the hours following 5-MeO-DMT as among the most peaceful of their lives — a state of profound openness and clarity that supports integration work.

Safety Considerations

5-MeO-DMT is generally considered safer from a physiological standpoint than ibogaine — it does not carry the same cardiac risks and does not require the same level of cardiac screening. However, it carries psychological risks that require appropriate set, setting, and support. Patients with psychosis, schizophrenia, or bipolar type I are generally not appropriate candidates. It should not be combined with SSRIs or MAOIs.

In the context of a combined ibogaine + 5-MeO-DMT program at a reputable clinic, these factors are managed by the treating medical team as part of the overall protocol.

Is the Combination Right for You?

The combined protocol is particularly common for patients seeking treatment for PTSD, complex trauma, depression, and anxiety. For patients focused primarily on opioid or substance detox, ibogaine alone is often the primary treatment, with 5-MeO-DMT as an optional add-on. We discuss this specifically during your consultation based on your individual situation and goals.

Questions about whether a combined ibogaine and 5-MeO-DMT protocol is appropriate for you? Our team is happy to walk through it in detail during a consultation.

Start a consultation →

To find a vetted clinic, browse our directory of 5-MeO-DMT treatment centers, or book a consultation to talk through whether this is right for your situation.

Ready to find a program? Browse our guide to vetted 5-MeO-DMT retreats.